98 related articles for article (PubMed ID: 16440306)
41. Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium.
Czarny M; Schnitzer JE
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1344-52. PubMed ID: 15142848
[TBL] [Abstract][Full Text] [Related]
42. Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis.
Nazzal D; Cantero AV; Therville N; Segui B; Negre-Salvayre A; Thomsen M; Benoist H
J Infect Dis; 2006 Jan; 193(1):136-45. PubMed ID: 16323142
[TBL] [Abstract][Full Text] [Related]
43. Glycoxidation of low-density lipoprotein promotes multiple apoptotic pathways and NFkappaB activation in human coronary cells.
de Nigris F; Gallo L; Sica V; Napoli C
Basic Res Cardiol; 2006 Mar; 101(2):101-8. PubMed ID: 16265596
[TBL] [Abstract][Full Text] [Related]
44. Aging in rat causes hepatic hyperresposiveness to interleukin-1beta which is mediated by neutral sphingomyelinase-2.
Rutkute K; Karakashian AA; Giltiay NV; Dobierzewska A; Nikolova-Karakashian MN
Hepatology; 2007 Oct; 46(4):1166-76. PubMed ID: 17668873
[TBL] [Abstract][Full Text] [Related]
45. Entamoeba histolytica: molecular cloning and characterization of a novel neutral sphingomyelinase.
Mendoza-Macías CL; Barrios-Ceballos MP; Anaya-Velázquez F; Nakada-Tsukui K; Nozaki T; Padilla-Vaca F
Exp Parasitol; 2010 Jul; 125(3):279-85. PubMed ID: 20138872
[TBL] [Abstract][Full Text] [Related]
46. Role of acidic sphingomyelinase in thymol-mediated dendritic cell death.
Xuan NT; Shumilina E; Schmid E; Bhavsar SK; Rexhepaj R; Götz F; Gulbins E; Lang F
Mol Nutr Food Res; 2010 Dec; 54(12):1833-41. PubMed ID: 20603831
[TBL] [Abstract][Full Text] [Related]
47. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein.
Augé N; Escargueil-Blanc I; Lajoie-Mazenc I; Suc I; Andrieu-Abadie N; Pieraggi MT; Chatelut M; Thiers JC; Jaffrézou JP; Laurent G; Levade T; Nègre-Salvayre A; Salvayre R
J Biol Chem; 1998 May; 273(21):12893-900. PubMed ID: 9582320
[TBL] [Abstract][Full Text] [Related]
48. Catabolism of native and oxidized low density lipoproteins: in vivo insights from small animal positron emission tomography studies.
Pietzsch J; Bergmann R; Wuest F; Pawelke B; Hultsch C; van den Hoff J
Amino Acids; 2005 Dec; 29(4):389-404. PubMed ID: 16012780
[TBL] [Abstract][Full Text] [Related]
49. Glucose metabolism is required for oxidized LDL-induced macrophage survival: role of PI3K and Bcl-2 family proteins.
Elsegood CL; Chang M; Jessup W; Scholz GM; Hamilton JA
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1283-9. PubMed ID: 19667115
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors.
Pitsinos EN; Wascholowski V; Karaliota S; Rigou C; Couladouros EA; Giannis A
Chembiochem; 2003 Nov; 4(11):1223-5. PubMed ID: 14613115
[No Abstract] [Full Text] [Related]
51. Vaspin attenuates the apoptosis of human osteoblasts through ERK signaling pathway.
Zhu X; Jiang Y; Shan PF; Shen J; Liang QH; Cui RR; Liu Y; Liu GY; Wu SS; Lu Q; Xie H; Liu YS; Yuan LQ; Liao EY
Amino Acids; 2013 Mar; 44(3):961-8. PubMed ID: 23135225
[TBL] [Abstract][Full Text] [Related]
52. Oxidized low-density lipoprotein (oxLDL) induces cell death in neuroblastoma and survival autophagy in schwannoma cells.
Nowicki M; Serke H; Kosacka J; Müller K; Spanel-Borowski K
Exp Mol Pathol; 2010 Dec; 89(3):276-83. PubMed ID: 20692253
[TBL] [Abstract][Full Text] [Related]
53. Long-Term Treatment of Native LDL Induces Senescence of Cultured Human Endothelial Cells.
Oh ST; Park H; Yoon HJ; Yang SY
Oxid Med Cell Longev; 2017; 2017():6487825. PubMed ID: 28197300
[TBL] [Abstract][Full Text] [Related]
54. Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells.
Hamel P; Abed E; Brissette L; Moreau R
Am J Physiol Cell Physiol; 2008 Apr; 294(4):C1021-33. PubMed ID: 18287334
[TBL] [Abstract][Full Text] [Related]
55. Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells.
Brodeur MR; Brissette L; Falstrault L; Ouellet P; Moreau R
Free Radic Biol Med; 2008 Feb; 44(4):506-17. PubMed ID: 18241787
[TBL] [Abstract][Full Text] [Related]
56. Phospholipase A2-modified low-density lipoprotein activates the phosphatidylinositol 3-kinase-Akt pathway and increases cell survival in monocytic cells.
Namgaladze D; Brüne B
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2510-6. PubMed ID: 16973971
[TBL] [Abstract][Full Text] [Related]
57. Total synthesis of (+)-scyphostatin, a potent and specific inhibitor of neutral sphingomyelinase.
Inoue M; Yokota W; Murugesh MG; Izuhara T; Katoh T
Angew Chem Int Ed Engl; 2004 Aug; 43(32):4207-9. PubMed ID: 15307088
[No Abstract] [Full Text] [Related]
58. Kaempferol inhibits apoptosis in vascular smooth muscle induced by a component of oxidized LDL.
Ruiz E; Padilla E; Redondo S; Gordillo-Moscoso A; Tejerina T
Eur J Pharmacol; 2006 Jan; 529(1-3):79-83. PubMed ID: 16325801
[TBL] [Abstract][Full Text] [Related]
59. Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells.
Loidl A; Sevcsik E; Riesenhuber G; Deigner HP; Hermetter A
J Biol Chem; 2003 Aug; 278(35):32921-8. PubMed ID: 12816958
[TBL] [Abstract][Full Text] [Related]
60. Concise approach to the carbocyclic core of the naturally occurring sphingomyelinase inhibitor scyphostatin.
Mehta G; Modugu NR
J Org Chem; 2013 Apr; 78(7):3367-73. PubMed ID: 23442124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
